Dietary Regulation of Histone Acetylases and Deacetylases for the Prevention of Metabolic Diseases

被引:57
|
作者
Pham, Tho X. [1 ]
Lee, Jiyoung [1 ]
机构
[1] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06269 USA
关键词
high-fat; HDAC; HAT; sulforpahane; curcumin; butyrate; epigenetics; HIGH-FAT-DIET; TRANSCRIPTION FACTOR NRF2; INSULIN-RESISTANCE; GLYCEMIC INDEX; PROINFLAMMATORY CYTOKINE; CELLULAR-METABOLISM; MATERNAL DIET; CANCER CELLS; IN-VIVO; DNA-PK;
D O I
10.3390/nu4121868
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Age-related diseases such as type 2 diabetes, cardiovascular disease, and cancer involve epigenetic modifications, where accumulation of minute changes in the epigenome over time leads to disease manifestation. Epigenetic changes are influenced by life style and diets. This represents an avenue whereby dietary components could accelerate or prevent age-related diseases through their effects on epigenetic modifications. Histone acetylation is an epigenetic modification that is regulated through the opposing action of histone acetylases (HATs) and deacetylases (HDACs). These two families of enzymes play critical roles in metabolic processes and their dysregulation is associated with pathogenesis of several diseases. Dietary components, such as butyrate, sulforaphane, and curcumin, have been shown to affect HAT and HDAC activity, and their health benefits are attributed, at least in part, to epigenetic modifications. Given the decades that it takes to accumulate epigenetic changes, it is unlikely that pharmaceuticals could undo epigenetic changes without side effects. Therefore, long term consumption of dietary components that can alter the epigenome could be an attractive means of disease prevention. The goal of this review is to highlight the roles of diets and food components in epigenetic modifications through the regulation of HATs and HDACs for disease prevention.
引用
收藏
页码:1868 / 1886
页数:19
相关论文
共 50 条
  • [21] Advanced Progress of Histone Deacetylases in Rheumatic Diseases
    Liu, Xue-Mei
    Yang, Liu
    Yang, Qi-Bin
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 947 - 955
  • [22] Inhibition of Histone Deacetylases in Inflammatory Bowel Diseases
    Glauben, Rainer
    Siegmund, Britta
    MOLECULAR MEDICINE, 2011, 17 (5-6) : 426 - 433
  • [23] Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases
    Sharma, Sorabh
    Sarathlal, K. C.
    Taliyan, Rajeev
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2019, 18 (01) : 11 - 18
  • [24] Histone deacetylases as targets in autoimmune and autoinflammatory diseases
    Hamminger, Patricia
    Rica, Ramona
    Ellmeier, Wilfried
    ADVANCES IN IMMUNOLOGY, VOL 147, 2020, 147 : 1 - 59
  • [25] Dysregulation of Histone Acetyltransferases and Deacetylases in Cardiovascular Diseases
    Wang, Yonggang
    Miao, Xiao
    Liu, Yucheng
    Li, Fengsheng
    Liu, Quan
    Sun, Jian
    Cai, Lu
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [26] The role of histone deacetylases in asthma and allergic diseases
    Bhavsar, Pankaj
    Ahmad, Tehireern
    Adcock, Ian M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (03) : 580 - 584
  • [27] Targeting Histone Deacetylases in Diseases: Where Are We?
    Benedetti, Rosaria
    Conte, Mariarosaria
    Altucci, Lucia
    ANTIOXIDANTS & REDOX SIGNALING, 2015, 23 (01) : 99 - 126
  • [28] Role of histone deacetylases and their inhibitors in neurological diseases
    Zhang, Li-Ying
    Zhang, Sen-Yu
    Wen, Ri
    Zhang, Tie-Ning
    Yang, Ni
    PHARMACOLOGICAL RESEARCH, 2024, 208
  • [29] Inhibition of Histone Deacetylases in Inflammatory Bowel Diseases
    Rainer Glauben
    Britta Siegmund
    Molecular Medicine, 2011, 17 : 426 - 433
  • [30] Histone deacetylases as targets for treatment of multiple diseases
    Tang, Jinhua
    Yan, Haidong
    Zhuang, Shougang
    CLINICAL SCIENCE, 2013, 124 (11-12) : 651 - 662